Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

BGIICC 2018 /
Management of inflammatory breast cancer

18th - 19th Jan 2018

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 26.01.18
Views: 2046

Prof Marwan Ghosn - Saint-Joseph University, Beirut, Lebanon

Prof Ghosn speaks with ecancer at the 10th BGICC in Cairo about diagnosis and treatment of inflammatory breast cancers in North Africa.

He describes the changing rate of disease development in the region, and molecular markers that may speed diagnosis and guide treatment.

Prof Ghosn notes a high mutational load in locally advanced tumours, with p53 among commonly associated genes, and the potential impact of checkpoint therapies in disease management once trial data becomes available.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation